Remove Economics Remove Medical Remove Sale
article thumbnail

The Perils of Customer Concentration in M&A

Focus Investment Banking

The Perils of Customer Concentration in M&A In the first half of 2025, we had the unfortunate experience of having to withdraw from the market two separate manufacturing businesses while they were in the middle of a sale process. The effect on the valuation and/or sale, is usually significant. Important information to be sure.

M&A 52
article thumbnail

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Cooley M&A

By 2030, more than 190 commercial drugs will lose patent exclusivity , putting at risk $236 billion in Big Pharma sales. The sale of Poseida Therapeutics, a cell and gene therapy-focused company, for up to $1.5 billion sale of Carmot Therapeutics, a promising Swiss GLP-1 drug developer, further underscores the sectors vitality.

M&A 64
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Financial Benefits of Diversification Through M&A

Sun Acquisitions

This can help to mitigate the impact of economic downturns, industry-specific challenges, or unforeseen events. Companies can attract new customers and improve their overall sales by offering a more comprehensive range of products or services. The company has acquired medical imaging, life sciences, and healthcare IT businesses.

M&A 62
article thumbnail

Using options to trade this beaten-down beer giant that Warren Buffett holds

CNBC: Investing

Studies, such as those cited in 2024 medical journals, link cannabis to increased risks of cardiovascular issues, mental health disorders and impaired cognitive function, particularly with heavy or chronic use. The rise of anti-obesity medications, such as GLP-1 receptor has raised concerns about their impact on alcohol consumption.

Trading 67
article thumbnail

Corporate Insights: Disclosing PHI Upon the Sale of a Medical Practice

JD Supra: Mergers

The Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (collectively, “HIPAA”) states that, absent patient authorization, a patient’s Protected Health Information (“PHI”) may not be disclosed to another Covered Entity (as defined by HIPAA) without a direct (..)

Medical 172
article thumbnail

2024 Key Deal Highlights and Predictions for 2025

Tyton Partners

The ongoing need for specialized skills, coupled with the rapid pace of technological advancement, suggests that corporate training will remain a strategic imperative for businesses seeking to adapt and thrive in an ever-changing economic landscape.

article thumbnail

10 Concepts We Can Learn About DSO/MSO From How2Exit's Interview W/Eric Gall

How2Exit

Through interviews with industry leaders, authors, mentors, and other influencers, we can gain insight into the process and ensure that the purchase and sale of a business is a successful and rewarding experience. There is no requirement to set up an MSO or DSO for the licensed medical professional.

Business 130